Intranasal deferoxamine can improve memory in healthy C57 mice, suggesting a partially non‐disease‐specific pathway of functional neurologic improvement

INTRODUCTION: Intranasal deferoxamine (IN DFO) has been shown to decrease memory loss and have beneficial impacts across several models of neurologic disease and injury, including rodent models of Alzheimer's and Parkinson's disease. METHODS: In order to assess the mechanism of DFO, determ...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Brain Behav
Main Authors: Fine, Jared M., Kosyakovsky, Jacob, Baillargeon, Amanda M., Tokarev, Julian V., Cooner, Jacob M., Svitak, Aleta L., Faltesek, Katherine A., Frey, William H., Hanson, Leah R.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2020
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7066355/
https://ncbi.nlm.nih.gov/pubmed/31960628
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/brb3.1536
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados